Increased expression of vascular endothelial growth factor in a case of protein-losing enteropathy with undifferentiated connective tissue disease

Int J Rheum Dis. 2018 Feb;21(2):566-570. doi: 10.1111/1756-185X.12417. Epub 2014 Jun 5.

Affiliations

¹ Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagaskai, Japan.
² Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Nagaskai, Japan.
³ Department of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagaskai, Japan.
⁴ Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagaskai, Japan.
⁵ Department of Clinical Pathology, Nagasaki University School of Medicine, Nagasaki, Japan.

PMID: 24899168
DOI: 10.1111/1756-185X.12417

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Biopsy
Female
Fluorescent Antibody Technique
Glucocorticoids / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Intestinal Mucosa / immunology
Intestinal Mucosa / metabolism*
Intestinal Mucosa / pathology
Middle Aged
Protein-Losing Enteropathies / drug therapy
Protein-Losing Enteropathies / etiology*
Protein-Losing Enteropathies / immunology
Protein-Losing Enteropathies / metabolism
Treatment Outcome
Undifferentiated Connective Tissue Diseases / complications*
Undifferentiated Connective Tissue Diseases / drug therapy
Undifferentiated Connective Tissue Diseases / immunology
Undifferentiated Connective Tissue Diseases / metabolism
Up-Regulation
Vascular Endothelial Growth Factor A / metabolism*

Substances

Glucocorticoids
Immunosuppressive Agents
VEGFA protein, human
Vascular Endothelial Growth Factor A